Target intelligence / Profile preview

PILR alpha associated neural protein (PIANP)

Target
PIANP
Molecular classification
Ligand (for PILRA, a receptor), Protein-coding gene, Other (immune regulatory protein)
01

Overview

PILR alpha associated neural protein (PIANP) is a protein-coding gene that encodes a ligand for the paired immunoglobulin-like type 2 receptor alpha (PILRA). PIANP is expressed in neural tissues, where it is believed to participate in immune regulation by modulating inhibitory signaling through interactions with its receptor. Its functions include potential involvement in innate immune responses and antigen processing, with particular relevance to neural tissue immunobiology. The gene is alternatively spliced, resulting in multiple transcript variants. No direct therapeutic drugs, safety liabilities, or biomarker status are currently associated with PIANP, but it may have implications for diseases involving neuroimmune mechanisms.

Other names
PILR alpha associated neural proteinPIANPC12orf53Brain protein 1 (mouse ortholog)PILR-associating neural protein (mouse ortholog)
02

Mechanism of action

Since PIANP is not currently a direct pharmacological target, there are no mechanisms of action described for drugs targeting this molecule specifically. For PILRA-targeted drugs (should they exist), mechanism might focus on disrupting or enhancing PIANP-PILRA binding, thereby modifying immunoregulatory signaling

03

Biological functions

Acts as a ligand for PILRA, modulating inhibitory immune signalingInvolved in innate immune system pathwaysPutative role in neural tissues, may affect neural immune environmentClass I MHC mediated antigen processing and presentationImmune regulation (potentially broad)
04

Disease associations

Immunological disorders (inferred from immune regulation roles)Potential roles in neurodegenerative diseases (expression in neural tissues)Other disease associations unconfirmed (no direct link to cancer or infection established; function mainly described as immune regulation ligand)
05

Safety considerations

No reported safety concerns or therapeutic liabilities directly associated with PIANPIf targeted, immunomodulatory effects could produce risks analogous to other immune pathway manipulation (e.g., infection susceptibility, excessive immune inhibition), but these are speculative

Beyond the preview

Go deeper on PILR alpha associated neural protein (PIANP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PILR alpha associated neural protein (PIANP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call